E
Acurx Pharmaceuticals, Inc. ACXP
$4.08 $0.225.70% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -4.52% 22.74% 1.41% 31.54% 5.85%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -7.51% -17.59% 15.39% -62.08% 2.53%
Change in Net Operating Assets 147.77% -4,842.86% -104.24% 1,401.82% -90.42%
Cash from Operations 18.57% 8.84% -2.77% 23.97% 5.96%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 3.42% 1,436.61% -87.78% 397.03% -92.90%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 3.42% 1,436.61% -87.78% 397.03% -92.90%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 51.54% 145.59% -243.62% 76.63% -276.96%